- About
- Advertise
- CureToday.com
- OncLive.com
- OncNursingNews.com
- TargetedOnc.com
- Contact
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2023 MJH Life Sciences™ and Cancer Network. All rights reserved.
Laura Anne Sena, MD, PhD | Authors
Investigational Treatment Approach Effective, Safe and Inexpensive in a Type of Prostate Cancer, Says Expert
December 31, 2022
Thus far, findings from 2 trials show that treatment with bipolar androgen therapy is associated with several benefits in patients with castration-resistant prostate cancer, according to an expert from Sidney Kimmel Comprehensive Cancer Center.
Multiple Molecular Mechanisms May Drive Responses to Investigational Prostate Cancer Treatment, Expert Says
December 29, 2022
Investigators have observed that treatment with bipolar androgen therapy has suppressed at least one oncogene in patients with castration-resistant prostate cancer who derived a response to therapy.
Advertisement
Advertisement